Stay updated on DECIDE Clinical Trial: Dapagliflozin vs. Standard Care

Sign up to get notified when there's something new on the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page.
Latest website image capture
Clouds background image

Latest updates to the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page

  1. Check
    3 days ago
    Change Detected
    Summary
    Minor metadata updates were made to the page, including the addition of related topics (MedlinePlus Genetics), a new study revision label (v3.3.1), and the removal of revision v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-24T14:48:33.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A government funding/operating-status notice was removed from the page; this does not affect the study details, eligibility criteria, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T06:54:44.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Removed 'Type 2 diabetes' and the related topic 'MedlinePlus Genetics' from the page's keywords/MeSH terms.
    Difference
    0.1%
    Check dated 2025-11-10T04:53:53.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    No additions or deletions detected between the old and new screenshots of the study page.
    Difference
    0.2%
    Check dated 2025-11-03T01:17:45.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    - Removed a MedlinePlus Genetics related topic: Type 2 diabetes, reducing the list of genetic topics covered on the page. This is a high-importance change as it eliminates a core health topic.
    Difference
    0.2%
    Check dated 2025-10-19T16:32:53.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Core page content updated to v3.2.0 and a new MedlinePlus Genetics topic (Type 2 diabetes) added; a government operating status notice was also added. Previous version v3.1.0 was removed.
    Difference
    3%
    Check dated 2025-10-05T10:16:34.000Z thumbnail image

Stay in the know with updates to DECIDE Clinical Trial: Dapagliflozin vs. Standard Care

Enter your email address, and we'll notify you when there's something new on the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page.